ResearcherMasaryk UniversityActive in the last 2 years

Radim Němeček

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6825-0960; OpenAlex author ID A5029943774. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 4

Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/life16091499 ↗
The role of neoadjuvant treatment in localized pancreatic cancer. Co-author DOI 10.48095/ccrvch2024429 ↗
Current diagnostic and treatment options for pancreatic cancer in 2024. Co-author PMID 39138013 ↗
Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. Co-author DOI 10.3390/biomedicines10102480 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michal Eid · 3 shared papers, 2022–2026 · strength 0.85
Petr Karásek · 1 shared paper, 2024 · strength 0.46
- Paper Current diagnostic and treatment options for pancreatic cancer in 2024. PMID 39138013 ↗
Annalisa Comandatore · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Ingrid Garajová · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Luca Morelli · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Geert Kazemier M · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Carsten Palnæs Hansen · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Elisa Giovannetti · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Inna Markovna Chen · 1 shared paper, 2026 · strength 0.24
- Paper Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.3390/life16091499 ↗
Miroslav Vrzal · 1 shared paper, 2022 · strength 0.15
- Paper Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. DOI 10.3390/biomedicines10102480 ↗
Petr Burkoň · 1 shared paper, 2022 · strength 0.15
- Paper Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. DOI 10.3390/biomedicines10102480 ↗
Jan Trna · 1 shared paper, 2022 · strength 0.15
- Paper Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. DOI 10.3390/biomedicines10102480 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.